Jubilant Pharmova
- Advice
- Hold
Jubilant Pharmova Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Jubilant Pharmova
Start SIPJubilant Pharmova Investment Rating
-
Master Rating:
-
Jubilant Pharmova has an operating revenue of Rs. 6,118.17 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 10% is healthy, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 46%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 17 which is a POOR score indicating inconsistency in earnings, a RS Rating of 24 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 183 | 215 | 200 | 29 |
| Operating Expenses Qtr Cr | 185 | 216 | 209 | 30 |
| Operating Profit Qtr Cr | -2 | 7 | -4 | -2 |
| Depreciation Qtr Cr | 12 | 11 | 9 | 2 |
| Interest Qtr Cr | 6 | 4 | 3 | 8 |
| Tax Qtr Cr | -5 | 6 | -1 | -1 |
| Net Profit Qtr Cr | -6 | 92 | -5 | -3 |
Jubilant Pharmova Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 353.66
- 50 Day
- 362.56
- 100 Day
- 366.22
- 200 Day
- 390.89
- 20 Day
- 353.32
- 50 Day
- 371.87
- 100 Day
- 361.51
- 200 Day
- 368.57
Jubilant Pharmova Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 356.57 |
| Second Resistance | 365.04 |
| Third Resistance | 371.42 |
| RSI | 39.1 |
| MFI | 48.83 |
| MACD Single Line | -7.34 |
| MACD | -7.36 |
| Support | |
|---|---|
| First Resistance | 341.72 |
| Second Resistance | 335.34 |
| Third Resistance | 326.87 |
Jubilant Pharmova Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 466,995 | 10,353,279 | 22.17 |
| Week | 172,446 | 5,364,801 | 31.11 |
| 1 Month | 92,763 | 3,722,568 | 40.13 |
| 6 Month | 252,457 | 9,093,493 | 36.02 |
Jubilant Pharmova Result Highlights
Jubilant Pharmova Synopsis
NSE-Medical-Diversified
Jubilant Pharmova is involved in the business activities of Manufacture of basic chemicals. Company’s Total Operating Revenue is Rs. 87.75 Cr. and Equity Capital is Rs. 15.93 Cr. for the Year ended 31/03/2022. Jubilant Pharmova Ltd. is a Public Limited Listed company incorporated on 21/06/1978 and has its registered office in the State of Uttar Pradesh, India. Company’s Corporate Identification Number(CIN) is L24116UP1978PLC004624 and registration number is 004624.| Market Cap | 5,474 |
| Sales | 639 |
| Shares in Float | 7.80 |
| No of funds | 150 |
| Yield | 1.45 |
| Book Value | 4.27 |
| U/D Vol ratio | 1.2 |
| LTDebt / Equity | 39 |
| Alpha | -0.12 |
| Beta | 0.82 |
Jubilant Pharmova
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 50.68% | 50.68% | 50.68% | |
| Mutual Funds | 0.4% | 0.39% | 0.04% | |
| Foreign Portfolio Investors | 23.38% | 23.06% | 23.47% | |
| Financial Institutions/ Banks | ||||
| Individual Investors | 18.68% | 19% | 19.35% | |
| Others | 6.86% | 6.87% | 6.46% |
Jubilant Pharmova Management
| Name | Designation |
|---|---|
| Mr. Shyam S Bhartia | Chairman |
| Mr. Hari S Bhartia | Co-Chairman & Manag. Director |
| Mr. R Kumar | Whole Time Director |
| Mr. Arvind Chokhany | Whole Time Director |
| Mr. Arun Seth | Independent Director |
| Mr. Priyavrat Bhartia | Director |
| Mr. Arjun Shanker Bhartia | Director |
| Mr. Vivek Mehra | Independent Director |
| Mr. Sushil Kumar Roongta | Independent Director |
| Ms. Sudha Pillai | Independent Director |
| Dr. Ashok Misra | Independent Director |
| Mr. S Sridhar | Independent Director |
Jubilant Pharmova Forecast
Price Estimates
Jubilant Pharmova Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-02-03 | Quarterly Results | |
| 2022-10-21 | Quarterly Results | |
| 2022-08-02 | Quarterly Results | |
| 2022-05-27 | Audited Results & Final Dividend | |
| 2022-02-04 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2022-08-12 | FINAL | Rs.5.00 per share(500%)Final Dividend |
| 2021-08-06 | FINAL | Rs.5.00 per share(500%)Final Dividend |
Jubilant Pharmova FAQs
What is Share Price of Jubilant Pharmova ?
Jubilant Pharmova share price is ₹342 As on 05 February, 2023 | 19:50
What is the Market Cap of Jubilant Pharmova ?
The Market Cap of Jubilant Pharmova is ₹5447.4 Cr As on 05 February, 2023 | 19:50
What is the P/E ratio of Jubilant Pharmova ?
The P/E ratio of Jubilant Pharmova is 56.4 As on 05 February, 2023 | 19:50
What is the PB ratio of Jubilant Pharmova ?
The PB ratio of Jubilant Pharmova is 1 As on 05 February, 2023 | 19:50